SOS
PFE icon

Silver Oak Securities’s Pfizer PFE Stock Holding History

Silver Oak Securities’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$394K Sell
16,359
-1,419
-8% -$37.1K 0.02% 538
2026
Q1 		$499K Sell
17,778
-2,267
-11% -$60.4K 0.04% 441
2025
Q4 		$501K Buy
20,045
+4,948
+33% +$125K 0.03% 459
2025
Q3 		$385K Buy
15,097
+1,878
+14% +$46.4K 0.03% 503
2025
Q2 		$320K Sell
13,219
-1,666
-11% -$38.9K 0.03% 527
2025
Q1 		$375K Sell
14,885
-1,001
-6% -$26.2K 0.03% 441
2024
Q4 		$420K Buy
15,886
+1,919
+14% +$52.1K 0.04% 424
2024
Q3 		$397K Buy
13,967
+3,486
+33% +$102K 0.04% 368
2024
Q2 		$293K Sell
10,481
-496
-5% -$13.7K 0.04% 294
2024
Q1 		$305K Sell
10,977
-2,391
-18% -$66.3K 0.05% 294
2023
Q4 		$385K Buy
13,368
+4,522
+51% +$137K 0.05% 329
2023
Q3 		$293K Sell
8,846
-5,872
-40% -$208K 0.06% 232
2023
Q2 		$540K Buy
14,718
+361
+3% +$14.1K 0.09% 212
2023
Q1 		$586K Buy
14,357
+355
+3% +$15.3K 0.1% 169
2022
Q4 		$717K Buy
14,002
+5,156
+58% +$247K 0.13% 122
2022
Q3 		$293K Sell
8,846
-4,813
-35% -$234K 0.06% 232
2022
Q2 		$701K Sell
13,659
-375
-3% -$19.1K 0.16% 107
2022
Q1 		$771K Buy
+14,034
New +$728K 0.16% 132

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Silver Oak Securities's PFE Position: Q2 2026 in Review

Silver Oak Securities reduced its Pfizer (PFE) stake by 8% in Q2 2026, selling an estimated $37.1K and leaving 16,359 shares worth $394K. The position accounts for 0.02% of the portfolio, ranked #538.

Silver Oak Securities first reported a position in PFE in Q1 2022 and has held it in 18 quarters since. The position peaked at $771K in Q1 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Silver Oak Securities held 16,359 shares of Pfizer worth $394K as of Q2 2026.
  • Silver Oak Securities sold 1,419 Pfizer shares in Q2 2026, an estimated $37.1K.
  • Pfizer made up 0.02% of Silver Oak Securities's portfolio in Q2 2026, its #538 holding.
  • Silver Oak Securities first reported a position in Pfizer in Q1 2022 and has held it in 18 quarters since.
  • Silver Oak Securities's Pfizer position peaked at $771K in Q1 2022.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Silver Oak Securities's 13F filing for Q2 2026, filed 7 Aug 2026.